Hideto Morimoto

536 total citations
18 papers, 390 citations indexed

About

Hideto Morimoto is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Hideto Morimoto has authored 18 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 8 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in Hideto Morimoto's work include Lysosomal Storage Disorders Research (14 papers), Trypanosoma species research and implications (7 papers) and Glycogen Storage Diseases and Myoclonus (7 papers). Hideto Morimoto is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Trypanosoma species research and implications (7 papers) and Glycogen Storage Diseases and Myoclonus (7 papers). Hideto Morimoto collaborates with scholars based in Japan and Brazil. Hideto Morimoto's co-authors include Ryûji Yamamoto, Tohru Hirato, Masafumi Kinoshita, Kohtaro Minami, Hiroyuki Sonoda, Katsuhiko Tachibana, Kenichi Takahashi, Toshitaka Fujisawa, Shuhei Yamada and Kazuyuki Sugahara and has published in prestigious journals such as International Journal of Molecular Sciences, Molecular Therapy and Molecular Pharmaceutics.

In The Last Decade

Hideto Morimoto

18 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideto Morimoto Japan 10 226 136 114 87 73 18 390
Mark L. Schultz United States 11 301 1.3× 197 1.4× 194 1.7× 161 1.9× 17 0.2× 19 570
Raphael Schiffmann United States 9 261 1.2× 299 2.2× 143 1.3× 67 0.8× 93 1.3× 10 539
Lucía Echevarría France 11 345 1.5× 355 2.6× 113 1.0× 158 1.8× 101 1.4× 15 680
Kayoko Katsuyama Japan 7 198 0.9× 166 1.2× 134 1.2× 53 0.6× 20 0.3× 7 383
Daniel K. Borger United States 8 257 1.1× 176 1.3× 145 1.3× 89 1.0× 11 0.2× 14 516
Susanna Lualdi Italy 19 371 1.6× 376 2.8× 106 0.9× 153 1.8× 48 0.7× 25 690
Barbara Tappino Italy 10 180 0.8× 161 1.2× 89 0.8× 84 1.0× 37 0.5× 16 361
Marialetizia Motta Italy 11 185 0.8× 195 1.4× 157 1.4× 105 1.2× 14 0.2× 20 416
Yumiko Taguchi Japan 9 213 0.9× 254 1.9× 156 1.4× 56 0.6× 14 0.2× 20 595
Mario A. Cabrera-Salazar United States 10 325 1.4× 169 1.2× 155 1.4× 100 1.1× 30 0.4× 11 396

Countries citing papers authored by Hideto Morimoto

Since Specialization
Citations

This map shows the geographic impact of Hideto Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideto Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideto Morimoto more than expected).

Fields of papers citing papers by Hideto Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideto Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideto Morimoto. The network helps show where Hideto Morimoto may publish in the future.

Co-authorship network of co-authors of Hideto Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hideto Morimoto. A scholar is included among the top collaborators of Hideto Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideto Morimoto. Hideto Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yoshioka, Aya, Hideto Morimoto, Noboru Tanaka, et al.. (2023). Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice. Molecular Therapy — Methods & Clinical Development. 29. 439–449. 11 indexed citations
2.
Morimoto, Hideto, Hidehiko Suzuki, Tomomi Masuda, et al.. (2023). Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice. Molecular Pharmaceutics. 20(11). 5901–5909. 4 indexed citations
3.
Morimoto, Hideto, et al.. (2022). Dose-dependent effects of a brain-penetrating iduronate-2-sulfatase on neurobehavioral impairments in mucopolysaccharidosis II mice. Molecular Therapy — Methods & Clinical Development. 25. 534–544. 9 indexed citations
4.
Minami, Kohtaro, Hideto Morimoto, Masafumi Kinoshita, et al.. (2022). Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses. International Journal of Molecular Sciences. 23(19). 11724–11724. 12 indexed citations
5.
Morimoto, Hideto, Masafumi Kinoshita, Noboru Tanaka, et al.. (2021). Clearance of heparan sulfate in the brain prevents neurodegeneration and neurocognitive impairment in MPS II mice. Molecular Therapy. 29(5). 1853–1861. 26 indexed citations
6.
Giugliani, Roberto, Ana Maria Martins, Torayuki Okuyama, et al.. (2021). Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data. International Journal of Molecular Sciences. 22(20). 10938–10938. 29 indexed citations
7.
Yoshioka, Aya, Masafumi Kinoshita, Hideto Morimoto, et al.. (2020). A novel approach to CNS dysfunction of Pompe disease with a fusion protein consisting of anti-transferrin receptor antibody and GAA enzyme. Molecular Genetics and Metabolism. 129(2). S150–S151. 3 indexed citations
8.
Kinoshita, Masafumi, et al.. (2019). Non-clinical evaluation of a blood-brain barrier-penetrating enzyme for the treatment of mucopolysaccharidosis type I. Molecular Genetics and Metabolism. 126(2). S83–S84. 5 indexed citations
9.
Maeda, Mitsuyo, Toshiyuki Seto, Hideto Morimoto, et al.. (2019). Autophagy in the Central Nervous System and Effects of Chloroquine in Mucopolysaccharidosis Type II Mice. International Journal of Molecular Sciences. 20(23). 5829–5829. 9 indexed citations
10.
11.
Sonoda, Hiroyuki, Hideto Morimoto, Masafumi Kinoshita, et al.. (2018). A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II. Molecular Therapy. 26(5). 1366–1374. 140 indexed citations
12.
Morimoto, Hideto, Minoru Horie, Noboru Tanaka, et al.. (2018). Non-clinical evaluation of JR-051 as a biosimilar to agalsidase beta for the treatment of Fabry disease. Molecular Genetics and Metabolism. 125(1-2). 153–160. 9 indexed citations
13.
Sonoda, Hiroyuki, et al.. (2017). Correction of central nervous system deficits in the mouse model of Hunter syndrome by recombinant iduronate 2-sulfatase crossing the blood-brain barrier. Molecular Genetics and Metabolism. 120(1-2). S125–S126. 5 indexed citations
14.
Higuchi, Takashi, Hiromi Shimizu, Takahiro Fukuda, et al.. (2012). Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. Molecular Genetics and Metabolism. 107(1-2). 122–128. 42 indexed citations
15.
Yamada, Shuhei, Hideto Morimoto, Toshitaka Fujisawa, & Kazuyuki Sugahara. (2007). Glycosaminoglycans in Hydra magnipapillata (Hydrozoa, Cnidaria): demonstration of chondroitin in the developing nematocyst, the sting organelle, and structural characterization of glycosaminoglycans. Glycobiology. 17(8). 886–894. 47 indexed citations
16.
Watanabe, Masao, et al.. (1978). The effect of ubiquinone-7 and its metabolites on the immune response. IV. Chemical structure-adjuvant activity relationship of quinonyl derivatives on humoral immune response.. PubMed. 48(3). 255–61. 1 indexed citations
17.
Sugimura, Kazuyuki, et al.. (1976). The effect of ubiquinone-7 and its metabolites on the immune response. III. The effect on the immune response to sheep erythrocytes and DNP-Lys-Ficoll in mice.. PubMed. 46(4). 464–71. 4 indexed citations
18.
Morimoto, Hideto, et al.. (1976). The effect of ubiquinone-7 and its metabolites on the immune response. II. Adjuvant activity on the circulating antibody production and the effect on the liver lysosomal membrane.. PubMed. 46(2). 192–203. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark L. Schultz Breakdown of academic impact, for papers by Raphael Schiffmann Breakdown of academic impact, for papers by Lucía Echevarría Breakdown of academic impact, for papers by Kayoko Katsuyama Breakdown of academic impact, for papers by Daniel K. Borger Breakdown of academic impact, for papers by Susanna Lualdi Breakdown of academic impact, for papers by Barbara Tappino Breakdown of academic impact, for papers by Marialetizia Motta Breakdown of academic impact, for papers by Yumiko Taguchi Breakdown of academic impact, for papers by Mario A. Cabrera-Salazar
Rankless by CCL
2026